Italy Peptide Receptor Radionuclide Therapy (Prrt) Market Estimated...

bir dosya eklendi Other

2023-12-13 12:32:32 -

Italy Peptide Receptor Radionuclide Therapy (Prrt) Market Estimated To Witness High Growth Owing To Increasing Incidence Of Neuroendocrine Tumors

The Italy Peptide Receptor Radionuclide Therapy (PRRT) market is estimated to be valued at US$ 591.83 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Peptide receptor radionuclide therapy or PRRT is a form of nuclear medicine therapy which is used for treating...

0 Yorumlar 0 hisse senetleri 795 Views 0 önizleme